Jan 14, 2021 / 12:30PM GMT
Unidentified Analyst -
Hello, everyone, and welcome back to the conference. I'm [Nater Sarabi]. I'm a member of JPMorgan's healthcare investment banking team. On behalf of JPMorgan, it's my pleasure to introduce Dr. Adi Hoess, the CEO of Affimed; and Alex Fudukidis, Affimed's Head of Investor Relations.
We'll try to reserve a few minutes at the end for Q&A. (Operator Instructions)
I'll now turn it over to Adi and Alex to tell you more about Affimed. Thank you.
Adi Hoess - Affimed N.V. - CEO, MD & Member of Management Board
Thank you, Nater, for the introduction, and welcome, everybody, to the Affimed presentation. And introducing to you the ways how we believe that we can advance immuno-oncology and our idea, in particular, is to activate the innate immune system, specifically natural killer cells and macrophages.
I'll move to Slide 3, that in the center of our thinking indeed is the patient. And we do indeed see lots of patients that are receiving treatments that have great benefit to them. But we're seeing probably many more
Affimed NV at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 14, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers